Table 1.
First author [Ref.], year | Age, years | Sex | Symptom | Tumor | Antibodies | Reduced intensity on T1- and incre-ased intensity on T2-weighted MRI |
---|---|---|---|---|---|---|
Nakae [1], 2014 | 72 | M | hemichorea | thymoma | no anti-CRMP5 | no |
Jiménez Caballero [2], 2014 | 69 | M | chorea | SCLC | positive anti-CRMP5/CV2 | no |
Bohrer [3], 2013 | 07 | M | choreo-dystonia | cardiac | no anti-CRMP5/CV2 or anti-NMDA | no |
Vick [4], 2012 | 69 | F | chorea | SCLC | positive anti-CRMP5 | yes |
Saito [5], 2009 | 63 | M | chorea | lung ACA | no anti-CRMP5 or anti-Yo | yes |
Martinkova [6], 2009 | 60 | F | chorea | breast | positive anti-Hu and anti-Ri | no |
Kleinig [7], 2009 | 73 | F | chorea | SCLC | no anti-Hu, anti-Ri or anti-Yo; anti-CRMP5 not tested | yes |
Kellinghaus [8], 2007 | 40 | M | chorea | testicular | positive anti-CRMP5 | no |
Krolak-Salmon [9], 2006 | 72 | M | chorea | lung ACA | positive anti-Yo | n.a. |
Dorban [10], 2004 | 48 | F | chorea | SCLC | positive anti-Hu; no anti-CRMP5/CV2 | yes |
Kinirons [11], 2003 | 62 | F | chorea | SCLC | positive anti-CRMP5 | yes |
Tan [12], 2003 | 62 | F | chorea | PCL | n.a. | n.a. |
Vernino [13], 2002 | 69 mean | 10 F 6 M | chorea | SCLC 12, renal 1, NHL 1, lung mass 2 | positive anti-CRMP5 in all | yes (n = 5), no (3), n.a. (8) |
Kujawa [14], 2001 | 55 | M | chorea | renal | n.a. | no |
Tani [15], 2000 | 73 | M | chorea | SCLC | positive 68-kDa antibody; no anti-Hu, anti-Yo and anti-Ri | yes |
Nuti [16], 2000 | 70 | M | chorea | NHL | no anti-Hu or anti-Yo; anti-CRMP5 not tested | n.a. |
ACA = Adenocarcinoma; NHL = non-Hodgkin lymphoma; PCL = primary cerebral lymphoma; n.a. = not assessed.